Biosynth Carbosynth, a supplier of services to the life sciences industry, has acquired Pepscan, a provider of peptide-based services.

The two companies will form Biosynth’s new peptide division, with offerings to the pharma & biotech industries.

Dr. Urs Spitz, CEO of Biosynth, said, “We are thrilled to be able to bring Pepscan’s outstanding peptide expertise into the group and form our new, global peptide division. This allows us to simplify the supply chains for our customers across life sciences, pharma and diagnostics, so they deal with one organization for all of their needs.”